| Literature DB >> 30862876 |
Mengchen Yin1, Junming Ma1, Jinhai Xu1, Lin Li2, Guanghui Chen3, Zhengwang Sun2, Yujie Liu2, Shaohui He2, Jie Ye4, Wen Mo5.
Abstract
The purpose of our study is to identify the predictive factors for a minimum clinically successful therapy after extracorporeal shock wave therapy for chronic plantar fasciitis. The demographic and clinical characteristics were evaluated. The artificial neural networks model was used to choose the significant variables and model the effect of achieving the minimum clinically successful therapy at 6-months' follow-up. The multilayer perceptron model was selected. Higher VAS (Visual Analogue Score) when taking first steps in the morning, presence of plantar fascia spur, shorter duration of symptom had statistical significance in increasing the odd. The artificial neural networks model shows that the sensitivity of predictive factors was 84.3%, 87.9% and 61.4% for VAS, spurs and duration of symptom, respectively. The specificity 35.7%, 37.4% and 22.3% for VAS, spurs and duration of symptom, respectively. The positive predictive value was 69%, 72% and 57% for VAS, spurs and duration of symptom, respectively. The negative predictive value was 82%, 84% and 59%, for VAS, spurs and duration of symptom respectively. The area under the curve was 0.738, 0.882 and 0.520 for VAS, spurs and duration of symptom, respectively. The predictive model showed a good fitting of with an overall accuracy of 92.5%. Higher VAS symptomatized by short-duration, severer pain or plantar fascia spur are important prognostic factors for the efficacy of extracorporeal shock wave therapy. The artificial neural networks predictive model is reasonable and accurate model can help the decision-making for the application of extracorporeal shock wave therapy.Entities:
Mesh:
Year: 2019 PMID: 30862876 PMCID: PMC6414656 DOI: 10.1038/s41598-019-39026-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Roles and Maudsley score.
| Score | Item | Content |
|---|---|---|
| 1 | excellent | no symptoms, unlimited walking ability without pain, patient satisfied with the treatment outcome |
| 2 | good | ability to walk for >1 hour without pain, symptoms decreased after treatment, patient satisfied with the treatment outcome |
| 3 | acceptable | inability to walk >1 hour without pain, symptoms somewhat improved and pain more tolerable than before treatment, patient slightly satisfied with the treatment outcome |
| 4 | poor | inability to walk without severe pain, symptoms not improved or even worsened after treatment, patient not satisfied with the treatment outcome |
Demographic and Clinical characteristics.
| Total 210 | ||
|---|---|---|
| Age (mean ± SD), years | 54.1 ± 13.6 | |
| Gender: male | 112(57.1%) | |
| BMI | <26 | 76(36.2%) |
| 26–30 | 112(53.3%) | |
| ≥30 | 22(10.5%) | |
| Affected bilateral side | 56(26.7%) | |
| Duration of symptoms (mean, range), days | 84.1(30,270) | |
| Roles and Maudsley score | 2.6 ± 0.5 | |
| VAS | 6.2 ± 1.9 | |
| Intensity Grade | low | 70(33.3%) |
| moderate | 70(33.3%) | |
| high | 70(33.3%) | |
| Oedema | 46(21.9%) | |
| Presence of heel spur in X-ray | 131(62.4%) |
SD: standard deviation.
The sample distribution of ANN model.
| Training sample | Testing sample | Keeping sample | Total | |
|---|---|---|---|---|
| Number | 118 | 40 | 52 | 210 |
Definition of the 10 predictive factors.
| Variable | Definition of Neurons | Type | Value |
|---|---|---|---|
| Age | The years of old | continuous | 18–79 |
| Gender | Male/Female | categorical | 0,1 |
| Affected bilateral side | Yes/No | categorical | 0,1 |
| Duration of symptoms | The days of duration | continuous | 30–270 |
| RM score | The number of RM score | categorical | 1,2,3,4 |
| VAS | The number of VAS | continuous | 0–10 |
| BMI | Height/Weight2 | categorical | 1,2,3 |
| Intensity grade | Low/Moderate/High | categorical | 1,2,3 |
| Oedema | Yes/No | categorical | 0,1 |
| Presence of heel spur | Yes/No | categorical | 0,1 |
Importance and value of the 10 independent variables.
| No | Variable | Importance | Normalized Importance | p-value |
|---|---|---|---|---|
| 1 | VAS | 0.261 | 100.0% | 0.012* |
| 2 | Presence of heel spur | 0.256 | 98.0% | 0.022* |
| 3 | Duration of symptoms | 0.098 | 37.6% | 0.021* |
| 4 | Age | 0.086 | 32.7% | 0.231 |
| 5 | Gender | 0.070 | 26.8% | 0.334 |
| 6 | BMI | 0.057 | 21.7% | 0.221 |
| 7 | RM score | 0.053 | 20.3% | 0.323 |
| 8 | Oedema | 0.050 | 19.2% | 0.341 |
| 9 | Affected bilateral side | 0.035 | 13.3% | 0.568 |
| 10 | Intensity grade | 0.034 | 12.8% | 0.654 |
*The three most predictive value factors.
Figure 1ANN model output diagram with insets for each layer.
The area under ROC curve and predictive values of ANN models and 3 individual parameters to predict the achievement of MCST.
| Characteristics/Model | Sensitivity (%) | Specificity (%) | AUC (95%CI) | PPV (%) | NPV (%) |
|---|---|---|---|---|---|
| VAS | 84.3 | 35.7 | 0.738(0.656–0.820) | 69 | 82 |
| Presence of heel spur | 87.9 | 37.4 | 0.882(0.829–0.935) | 72 | 84 |
| Duration of symptoms | 61.4 | 22.3 | 0.520(0.437–0.604) | 57 | 59 |
Note: PPV, positive predictive value; NPV, negative predictive value.
Figure 2ROC curve based on ANN model contains Duration of symptom, Presence of heel spur and VAS score.
Predictive model established by ANN model (n = 210).
| Observed | Predicted | ||
|---|---|---|---|
| Not Achieved MSCT | Achieved MSCT | Percentage Correct | |
| Not Achieved MSCT | 63 | 7 | 90.0% |
| Achieved MSCT | 7 | 133 | 95.0% |
| Overall Percentage | 92.5% | ||
Note: χ2 = 6.635, df = 8, P = 0.577, overall accuracy 92.5%.